How to buy Agile Thrpe stock (AGRX)

Agile Thrpe is a drug manufacturers - specialty & generic business based in the US. Agile Thrpe shares (AGRX) are listed on the NASDAQ and all prices are listed in US Dollars. Agile Thrpe employs 19 staff and has a trailing 12-month revenue of around $21.6 million.

Our top picks for where to buy Agile Thrpe stock

Buy Agile Thrpe stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Agile Thrpe stock price (NASDAQ: AGRX)

Use our graph to track the performance of AGRX stocks over time.

Agile Thrpe shares at a glance

• Key figures

Information last updated 2024-10-20.

52-week range	$0.20 - $1.98
50-day moving average more info button	$1.31
200-day moving average more info button	$1.11
Wall St. target price	$5.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.70

Is it a good time to buy Agile Thrpe stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Agile Thrpe financials

Revenue TTM	$21.6 million
Gross profit TTM	$-6,617,000
Return on assets TTM	-61.55%
Return on equity TTM	-1364.04%
Profit margin	-73.52%
Book value	$-3.17
Market Capitalization more info button	$10.4 million

TTM: trailing 12 months

Agile Thrpe share dividends

We're not expecting Agile Thrpe to pay a dividend over the next 12 months.

Have Agile Thrpe's shares ever split?

Agile Thrpe's shares were split on a 1:50 basis on 10 April 2023 . So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Agile Thrpe shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Agile Thrpe shares which in turn could have impacted Agile Thrpe's share price.

Agile Thrpe share price volatility

Over the last 12 months, Agile Thrpe's shares have ranged in value from as little as $0.2 up to $1.975. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Agile Thrpe's is 1.582. This would suggest that Agile Thrpe's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Agile Thrpe overview

Agile Therapeutics, Inc. , a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey. As of August 26, 2024, Agile Therapeutics, Inc.

Frequently asked questions

null
What percentage of Agile Thrpe is owned by insiders or institutions?
Currently 9.698% of Agile Thrpe shares are held by insiders and 16.021% by institutions. How many people work for Agile Thrpe?
Latest data suggests 19 work at Agile Thrpe. When does the fiscal year end for Agile Thrpe?
Agile Thrpe's fiscal year ends in December. Where is Agile Thrpe based?
Agile Thrpe's address is: 500 College Road East, Princeton, NJ, United States, 08540 What is Agile Thrpe's ISIN number?
Agile Thrpe's international securities identification number is: US00847L1008 What is Agile Thrpe's CUSIP number?
Agile Thrpe's Committee on Uniform Securities Identification Procedures number is: 00847L100